Mesoblast (MEOBF) Operating Leases (2019 - 2026)
Mesoblast's (MEOBF) quarterly Operating Leases came in at $3.0 million in Q2 2026, up 13.1% year-over-year from $2.7 million in Q2 2025, and up 27.25% quarter-over-quarter from $2.4 million in Q4 2025.
Analysis
Mesoblast (MEOBF) Operating Leases (2019 - 2026) Analysis & Trends
Mesoblast has disclosed Operating Leases across 8 years of filings, most recently posting $3.0 million for Q2 2026.
- In Q2 2026, Operating Leases rose 13.1% year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at $3.0 million (up 13.1% YoY), while the FY2026 annual figure was $3.0 million, up 13.1% from the prior year.
- Operating Leases came in at $3.0 million for Q2 2026 at Mesoblast, up from $2.4 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $4.1 million in Q2 2023 to a low of $2.4 million in Q4 2024.
- Average Operating Leases over 5 years is $3.1 million, with a median of $2.9 million recorded in 2023.
- Year-over-year, Operating Leases jumped 48.29% in 2023 and sank 35.32% in 2024.
- Over 5 years, Operating Leases stood at $3.9 million in 2022, then slipped by 26.14% to $2.9 million in 2023, then dropped by 16.49% to $2.4 million in 2024, then climbed by 0.04% to $2.4 million in 2025, then advanced by 27.25% to $3.0 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $3.0 million in Q2 2026, $2.4 million in Q4 2025, and $2.7 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.03 Mn |
| Dec 31, 2025 | 2.38 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Dec 31, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Dec 31, 2023 | 2.85 Mn |
| Jun 30, 2023 | 4.06 Mn |
| Mar 31, 2023 | 3.61 Mn |
| Dec 31, 2022 | 3.86 Mn |
| Sep 30, 2022 | 3.61 Mn |
| Jun 30, 2022 | 3.19 Mn |
| Mar 31, 2022 | 2.43 Mn |
| Dec 31, 2021 | 3.49 Mn |
| Sep 30, 2021 | 3.14 Mn |
| Jun 30, 2021 | 2.77 Mn |
| Mar 31, 2021 | 2.84 Mn |
| Dec 31, 2020 | 2.55 Mn |
| Sep 30, 2020 | 2.98 Mn |
| Jun 30, 2020 | 3.52 Mn |
| Mar 31, 2020 | 3.06 Mn |